Medicines Discovery Catapult (MDC) appointed Baxter Neumann in 2021 to help them strengthen their leadership team. Our work has resulted in two senior Executive appointments in 2022:
Chief Financial Officer, Sinéad  McCormack and Robert Sherville-Payne as General Counsel. MDC are reshaping the UK’s medicines discovery industry, driving the adoption of new technologies and innovation.